bn 50739 has been researched along with flunitrazepam in 1 studies
| Studies (bn 50739) | Trials (bn 50739) | Recent Studies (post-2010) (bn 50739) | Studies (flunitrazepam) | Trials (flunitrazepam) | Recent Studies (post-2010) (flunitrazepam) |
|---|---|---|---|---|---|
| 57 | 0 | 1 | 2,697 | 298 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, JM; Olson, MS; Svetlov, SI | 1 |
1 other study(ies) available for bn 50739 and flunitrazepam
| Article | Year |
|---|---|
The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Azepines; Benzodiazepinones; Bicuculline; Cells, Cultured; Clonazepam; Convulsants; Flunitrazepam; Kinetics; Liver; Male; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazoles; Tritium | 1996 |